期刊文献+

246例乳腺癌临床病理因素的预后分析 被引量:4

The prognosis analysis of clinical pathology characteristic in 246 breast carcinomas
在线阅读 下载PDF
导出
摘要 目的分析246例乳腺癌临床病理特性对判断预后的价值。方法选取徐州医学院附属医院1999~2001年有确切随访资料的246例乳腺癌患者,采用Kaplan-meier法与Cox回归模型评估各因素对乳腺癌预后的影响。结果本组246例乳腺癌病例5年总体生存率为79.02%,使用SPASS软件进行Pro Logistic回归分析患者5年总体生存率与绝经状况、肿瘤大小复发情况、腋窝淋巴结转移、TNM分期、化疗、内分泌治疗、放疗均显著相关而与PR、ER、病理类型和年龄无明显关系。单因素分析淋巴结状态和复发情况是乳腺癌患者独立危险因素,且多因素分析淋巴结状态和复发情况是女性乳腺癌患者最明显的预后协同危险因素。结论患者绝经状况、肿瘤大小、复发情况、腋窝淋巴结转移、TNM分期、化疗、内分泌治疗、放疗的不同水平5年生存率有显著差异。淋巴结转移和复发情况不仅是影响乳腺癌患者预后的独立危险因素,同时更是影响乳腺癌预后的联合危险因素。 Objective To Analyze clinical pathology characteristic in 246 breast carcinomas and evaluate the value.Methods 246 cases with breast carcinomas were selected in affiliated hospital of Xuzhou between 1999 and 2001,adopted Kaplan-meier method and Cox return to evaluate influence of each factor to the mammary glands cancer.Results The survival rate of 246 cases with breast carcinomas for total 5 years is 79.02%,usage the SPASS 11.0 software carry on Pro Logistic back to return analysis sufferer total for 5 years survival rate with menopause,relapse,tumor size,lymphoid knot transfer,TNM stage,chemotherapy,endocrine treatment,radiotherapy to all show significant correlated but with PR,ER,pathology type and age had no obvious relation.List factor analysis lymphoid knot transfer and relapse were independence dangerous factors of breast carcinoma,and many factor analysis lymphoid knot transfer and relapse were in conjunction with dangerous factor of breast carcinoma.Conclusions Menopause,tumor size,relapse,lymphoid knot transfer,TNM stage,chemotherapy,endocrine treatment,radiotherapy of dissimilarity level which have already shown significant deviation of 5 years survival rate.Lymphoid knot transfer and relapse is not only independent dangerous factor to breast carcinomas prognosis,but also relevant factors.
出处 《齐齐哈尔医学院学报》 2011年第24期3958-3960,共3页 Journal of Qiqihar Medical University
关键词 乳腺癌 生存率 预后 Breast carcinomas Survival rate Prognosis
  • 相关文献

参考文献15

  • 1Manseur EG, Ravdin PM, Dressier L. Prognostic factors in ear- ly breast cancer[J]. Cancer, 1999,74 : 381 - 385.
  • 2Mcguire WL, Tandon AK, Allred DC. How to iise prognostic fac tots in axillary node negative breast cancer patients[J]. J Natl Cancer Inst,2001,82:l 006-1 012.
  • 3Shaheenah Dawood, Kristine Broglio, Shu-Wan Kau, et al. Prognostic value of initia clinical disease stage after achieving pathological complete response [J]. TheOncologist, 2008, 13 : 6-15.
  • 4Early Breast Cancer Trialists'Collaborative Group(EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:An overview of the randomized trials[J]. Lancet, 2005,365 : 1 687- 1 717.
  • 5Morris SR,Carey LA. Molecular profiling in breast cancer[J]. Rev Endocr Metab Disord, 2007,8 : 185 - 198.
  • 6Goldhirsch A,Glick JH, Gelber RD, et al. Meeting highlights : international expert consensus on the primary therapy of early breast cancer 2005 [J]. Ann Oncol, 2005,16 : 1 569- 83.
  • 7Colleoni M, Potmensz N, Robertson C, et al. Very young women (<35years)withoperable breast cancer :features of disease at pre senta -tion[J]. Ann Oneology,2002,13(2) :273-279.
  • 8Kothari AS, Beechey- Newman N, Arrigo C, et al. Breast car- cinoma in women age 25 years or less[J]. Cancer,2002,94(3) : 606-614.
  • 9Vorgias G,Koukouras D,Paleogiannoi V, et al. Prognostic signifi- ca -nce of factors affecting disease free interval and overall survival for Sta -ge breast cancer in Greece[J]. A multivariate cohort study. Eur JObstet Gyn -cool Reprod Biol,2001,95(1):100-104.
  • 10Kothari AS, Beechey- Newman N, Arrigo C, et al. Breast car cinoma in women age 25years or less[J]. Cancer, 2002,94 (3) : 606-614.

同被引文献35

  • 1魏丽珍,林梅,何宏涛,宋琳,王士杰.1767例乳腺癌临床特点与发病因素分析[J].河北医科大学学报,2009,30(2):155-157. 被引量:10
  • 2侯红波,田力平.乳腺癌210例预后影响因素分析[J].苏州大学学报(医学版),2006,26(1):154-156. 被引量:5
  • 3李沛雨,陈凛,李荣,徐文通,蒋彦永.早期乳腺癌保乳治疗的局部复发因素分析[J].军医进修学院学报,2007,28(1):17-19. 被引量:1
  • 4何英,唐利立.国人早期乳腺癌远处转移预报模型的研究[J].中国普通外科杂志,2007,16(4):360-362. 被引量:3
  • 5中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2007版)[J].中国癌症杂志,2007,17(5):410-428. 被引量:235
  • 6Bock GH,Putter H,Bonnema J, et al. The impact of locore- gional recurrences on metastatic progression in early-stage breast cancer:A muhistate model [J].Breast Cancer Res Treat,2009 117(2) :401-408.
  • 7Botteri E,Bagnardi V,Rotmensz N,et al. Analysis of local and regional recurrences in breast cancer after conservative surgery [J]. Ann Oncol,2010,21 (4) :723-728.
  • 8Bouganim N,Tsvetkova E,Clemons M,et al. Evolution of sites of recurrence after early breast cancer over the last 20 years : implications for patient care and future research [J]. Breast Cancer Res Treat, 2013,139 C 2 ) : 603-606.
  • 9Lower EE,Glass E,Blau R,et al. HER-2/neu expression in primary and metastatic breast cancer [J]. Breast Cancer Res Treat, 2009,113 (2) : 301-306.
  • 10Santinelli A,Pisa E,Stramazzotti D,et al. HER-2 status discrepancy between primary breast cancer and metastaticsites.Impact on target therapy [J]. International Journal of Cancer,2008,122(5) :999-1004.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部